Market Research Logo

POCT Market in the US 2015-2019

About POCT

POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.
The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count.

Technavio's analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the POCT market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of POCT diagnostic devices. The market is segmented based on application:
Blood glucose testing
Infectious disease testing
Cardiac markers testing
Pregnancy and fertility testing
Blood gas/electrolyte testing
Tumour markers testing
Urinalysis testing
Cholesterol testing

Technavio's report, POCT Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the key vendors in the market. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
Abbott diagnostics
Alere
Roche Diagnostics
Siemens Diagnostics

Other prominent vendors
Abaxis
Acon Laboratories
Avioq
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
Hologic
i-Sens
Landwind Medical
Mindray
Nipro Diagnostics
Randox Laboratories
Span Diagnostics
Sysmex
Thermo Fisher Scientific
Trivitron Healthcare
URIT

Market driver

North America free trade agreement
For a full, detailed list, view our report

Market challenge

Limitation of POCT products
For a full, detailed list, view our report

Market trend

Key role of USAMRIID
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors


Press Release

Technavio Announces the Publication of its Research Report POCT Market in the US 2015-2019

Technavio recognizes the following companies as the key players in the POCT Market in the US: Abbott Diagnostics, Alere, Roche Diagnostics and Siemens

Other Prominent Vendors in the market are: Abaxis, Acon Laboratories, Avioq, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, Hologic, Thermo Fisher Scientific, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Sysmex, Trivitron Healthcare, and URIT.

Commenting on the report, an analyst from Technavios team said: The current market trends such as the introduction of low-cost microfluidic devices will also fuel market growth. The development of POCT devices with nano or microfluidic technologies is an emerging tool by which to detect infectious diseases. For instance, SurModics has incorporated this technology into a few of its IVD products. This technology will reduce the cost of the product as it requires less reagent and consumes less power.

According to the report, the growth of the POCT market in the US is driven by numerous factors, one of which is the NAFTA. This agreement has increased the US exports of diagnostics and has reduced the tariffs and has opened its procurement market in Mexico and Canada, which has reduced trade barriers and increased sales in these region. It has helped the US to compete with other countries such as Germany and Japan.

Further, the report states that the development of an integrated POCT product is a major challenge for vendors because of the limited lifespan of the biomolecules that need to be tested and the quality control issues associated with POCT devices.

Companies Mentioned

Abbott Diagnostics, Alere, Roche Diagnostics, Siemens, Abaxis, Acon Laboratories, Avioq, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, Hologic, Thermo Fisher Scientific, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Sysmex, Trivitron Healthcare, URIT.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table POCT market in US 2014-2019 ($ millions)
  • Healthcare reform in US
    • Introduction of PPACA
      • Table PPACA benefits for US citizens
      • Table Comparison of US healthcare provision pre and post reform
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • Table Segmentation of POCT market in US by application
    • Blood glucose testing market in US
      • Table Blood glucose testing market in US 2014-2019 ($ millions)
    • Infectious disease testing market in US
      • Table Infectious disease testing market in US 2014-2019 ($ millions)
    • Cardiac marker testing market in US
      • Table Cardiac marker testing market in US 2014-2019 ($ millions)
    • Coagulation testing market in US
      • Table Coagulation testing market in US 2014-2019 ($ millions)
    • Pregnancy and fertility testing market in US
      • Table Pregnancy and fertility testing market in US 2014-2019 ($ millions)
    • Blood gas/electrolyte testing market in US
      • Table Blood gas/electrolyte testing market in US 2014-2019 ($ millions)
    • Tumor marker testing market in US
      • Table Tumor marker testing market in US 2014-2019 ($ millions)
    • Urinalysis testing market in US
      • Table Urinalysis testing market in US 2014-2019 ($ millions)
    • Cholesterol testing market in US
      • Table Cholesterol testing market in US 2014-2019 ($ millions)
      • Table Segmentation of POCT market in US by application 2014POCT market in US by application 2014
  • Market drivers
    • Influence of NAFTA
    • Demand for rapid and automated diagnostics
    • POCT at home
    • Technological innovations
    • Collaborations and M&A to enhance POCT technology
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Issues of intellectual property rights
    • Threat of low-cost products
    • Product recalls
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Shift toward patient-centered model
    • Low-cost microfluidic devices for POCT
    • Growing popularity of portable POCT products
    • Role of USAMRIID
  • Vendor landscape
    • Competitive scenario
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key takeaways
    • Alere
      • Table Alere: Key takeaways
    • Roche Diagnostics
      • Table Roche Diagnostics: Key takeaways
    • Siemens Diagnostics
      • Table Siemens Diagnostics: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • Alere
      • Table Alere: Business Segmentation by revenue 2014
      • Table Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
    • Roche Diagnostics
      • Table Roche Diagnostics: Business segmentation by revenue 2014
      • Table Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Roche Diagnostics: Geographical segmentation by revenue 2014
    • Siemens Healthcare
      • Table Siemens Healthcare: Business segmentation
      • Table Siemens Healthcare: Geographical segmentation by revenue 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report